Premium telehealth may have been possible before, but it’s never before been effectively commercialized. With our telehealth solutions we aim to blend state-of-the-art diagnostics, broadband network access and HD communications equipment to empower doctors, patients and clinicians.
The UniDoc Virtual Care model is being designed to remove the barriers between patients and care providers. The Company is aiming to set a new standard of care with virtual visits and fully-integrated diagnostic tools.
Once ready for deployment, anticipated benefits include the following:
Providing virtual healthcare visits in the comfort of a patient’s home or at a local point of service.
Physicians have full access to the patients' clinical data and vital signs in real time.
Lowering the financial barriers of in-house physicians’ recruitment and retention
As digital transformation continues permeating the healthcare industry, telehealth is gaining momentum as an increasingly popular alternative to traditional clinical care.
Telehealth, an integral part of home-based care, first found its niche with seniors: According to AARP, 87% of adults age 65 and older want to stay in their current home and community as they age. But now that Medicare telehealth regulations are loosening, its popularity will only increase.
The aging population isn’t the only group that stands to benefit from telehealth programs: Healthcare organizations that offer them are already earning early dividends, including cost avoidance, lowered readmission rates, and a greater number of patients served.
And as technological advancements enable a prevention and wellness-based model, and consumer preferences shift in favor of more personalized care, consumers are opening up to these virtual solutions. In fact, 57% said they’d use telehealth for a remote general consultation if given the option, according to the 2018 Business Insider Intelligence Insurance Technology Study.
Deloitte estimates that US health spending will balloon from 2020’s$4 trillion estimate to $8.3 trillion by 2040. A main driver of these high costs is healthcare companies’ adoption of emerging health-focused technology. We estimate that US healthcare providers and facilities spent $11.36 billion on cloud-based technologies in 2020—up 33.0% from 2019, when they spent $8.55 billion.
To offset costs, healthcare providers are leveraging the increase in consumers who want to play a more active role in monitoring their own health by encouraging tech that promotes vital tracking, early detection, and prevention of disease. Specifically, remote patient monitoring (RPM) tools, which enable a continuous stream of real-time health data between patients and their doctors, will account for much of this savings.
Telehealth is the use of digital technologies to deliver medical care, health education, and public health services by connecting multiple users in separate locations. Telehealth encompasses a broad definition of technology-enabled health care services. Telehealth includes telemedicine (diagnosis and treatment of illness or injury – see detailed description below), and services such as assessment, monitoring, communications, prevention, and education. It involves a broad range of telecommunications, health information, videoconferencing, and digital image technologies.
"*" indicates required fields
Enter your details below and we will add you to our News Alerts list.
Mr. Pirooz is a registered and practicing pharmacist, and has been a professional member of the College of Pharmacists of British Columbia since 2003, with over 20 years of pharmaceuticals and pharmacy management experience. As owner of a compounding pharmacy, Mr. Pirooz has been dispensing pharmaceuticals for over 18 years and provides pharmacist and pharmacy management services to many of Canada’s largest pharmacy chains and drug stores. Mr. Pirooz is also the CEO and a director of Genix Pharmaceuticals Corporation, a company listed for trading on the TSXV.
He is the former Chief Scientific Officer of InMed Pharmaceuticals Inc., a leading public Canadian bio-pharmaceutical company. Previously he worked as Senior Scientist at Biotechnology Research Institute of National Research Council Canada. Working with the Canadian government he helped establish the pharmacology laboratory to evaluate safety and efficacy of cannabinoid-based and other drugs under development for cancer, cardiovascular and ocular diseases.
Jacob is the CEO & founder of MoviWear a GPS, fall down detection & remote vital-sign monitoring platform, alerting caregivers of real-time emergencies. Jacob is a communications and technology expert with over 15 years’ experience in the field. the NurtureWatch health monitoring Smartwatch and MoviWearMED remote vital sign monitoring platform Prior to MoviWear, Jacob worked in both the Canadian telecom and the CPG industry. He led the Product Development and Business Strategy team at TELUS for the Small Business Portfolio. Jacob also worked in various product and service management roles within Rogers Communications where he launched and managed wireless and wireline products.
Mr. Baldassarre has held senior management and director positions of new business start-ups and established multinational organizations with over 30 years of experience in the Security, Information Technology and Communications industries. With leadership skills in management of international operations, shareholder exit strategies, and overall business development, he has utilized a wide range of strategic programs to maximize organic growth into specific industry segments through OEM, alliances, and direct multi-level distribution channels. Mr. Baldassarre is able to plan, organize and direct all aspects of a Corporation from Operations, P&L oversight, product distribution, Product promotions, sales and development activities and initiatives utilizing my extensive marketing/sales senior management experience with developed abilities in team leadership and program/campaign development. Directly involved in the growth, branding and ultimately optimizing market share, product awareness, revenues, profitability and shareholder value. Mr. Baldassare is also the President of LRG Security Canada Inc. and LRG Security Europe.
Mr. Franco Staino is the Developer of the Italian National anti-counterfeiting Program for Pharmaceuticals developed in conjunction with the Ministry of Health as well as the National Certification Program for all unsold Prescription Drugs in Partnership with Pharmindustria (National association of all Pharmaceutical Manufactures) through ASSINDE.
Through one of his Companies, Carlucci are responsible for the control, labelling and collection of all pharmaceutical prescription drugs in Italy, under the PHG umbrella Franco opened first a UK division, now has also expanded into 4 African countries. Over the Years Franco has been a Board Member and Contributor on various International Committees, including the United Nations.